WAM
Weiss Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,910
| Closed | -$263K | – | 364 |
|
|
2024
Q1 | $263K | Sell |
1,910
-12,586
| -87% | -$1.74M | 0.01% | 220 |
|
|
2023
Q4 | $1.91M | Buy |
+14,496
| New | +$1.91M | 0.09% | 84 |
|
|
2022
Q4 | – | Sell |
-3,500
| Closed | -$372K | – | 606 |
|
|
2022
Q3 | $372K | Buy |
+3,500
| New | +$372K | 0.01% | 534 |
|
|
2018
Q4 | – | Sell |
-7,865
| Closed | -$967K | – | 471 |
|
|
2018
Q3 | $967K | Hold |
7,865
| – | – | 0.07% | 93 |
|
|
2018
Q2 | $773K | Hold |
7,865
| – | – | 0.08% | 94 |
|
|
2018
Q1 | $652K | Hold |
7,865
| – | – | 0.05% | 98 |
|
|
2017
Q4 | $610K | Buy |
7,865
+4,358
| +124% | +$338K | 0.05% | 98 |
|
|
2017
Q3 | $215K | Buy |
+3,507
| New | +$215K | 0.02% | 83 |
|